• ISBN13: 9781849731256
• Binding: Hardcover
• Subject: Bio-Science and Agriculture
• Publisher: Royal Society of Che
• Publisher Imprint: RSC
• Publication Date: June 15, 2011
• Pages: 328
• Original Price: GBP 132.99
• Language: English
• Edition: N/A
• Item Weight: 626 grams

About the Book Despite ever increasing research investment, there has been a decline in the number of new drug approvals over the last decade. In order to improve productivity, the drug discovery community is exploring alternative approaches. The emerging field of chemical biology utilizes the tools and techniques of chemical synthesis to study and influence biochemical systems. It has already led to the identification of novel therapeutic targets and will continue to facilitate drug discovery in the 21st century. This book highlights the new frontiers in chemical biology and describes their impact and future potential. It provides a valuable resource for scientists in academia and industry who are looking to build their knowledge of this hot topic.

Mark read chemistry at the University of Durham, completed his DPhil with Professor S.G. Davies at the University of Oxford, and then moved to The Scripps Research Institute to work with Professor K.C. Nicolaou as a NATO postdoctoral fellow. Mark joined Pfizer in the UK as a medicinal chemist in 1996 and since then has assumed a number of roles of increasing responsibility. Mark is currently the Head of Medicinal Chemistry for Pfizer in Sandwich. Mark has broad interests in medicinal chemistry and is an author or inventor on over 50 publications and patents.